• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类挑战研究简史(1900-2021),重点介绍病毒学、监管和伦理要求、存在理由、民族志、志愿者选择和单位设计。

A Brief History of Human Challenge Studies (1900-2021) Emphasising the Virology, Regulatory and Ethical Requirements, Raison D'etre, Ethnography, Selection of Volunteers and Unit Design.

机构信息

Blizzard Institute of Cell and Molecular Science, Queen Mary University of London, London, E1 2AT, UK.

hVIVO, London, UK.

出版信息

Curr Top Microbiol Immunol. 2024;445:1-32. doi: 10.1007/82_2022_253.

DOI:10.1007/82_2022_253
PMID:35704095
Abstract

Venetian quarantine 400 years ago was an important public health measure. Since 1900 this has been refined to include "challenge" or deliberate infection with pathogens be they viruses, bacteria, or parasites. Our focus is virology and ranges from the early experiments in Cuba with Yellow Fever Virus to the most widespread pathogen of our current times, COVID-19. The latter has so far caused over four million deaths worldwide and 190 million cases of the disease. Quarantine and challenge were also used to investigate the Spanish Influenza of 1918 which caused over 100 million deaths. We consider here the merits of the approach, that is the speeding up of knowledge in a practical sense leading to the more rapid licensing of vaccines and antimicrobials. At the core of quarantine and challenge initiatives is the design of the unit to allow safe confinement of the pathogen and protection of the staff. Most important though is the safety of volunteers. We can see now, as in 1900, that members of our society are prepared and willing to engage in these experiments for the public good. Our ethnology study, where the investigator observed the experiment from within the quarantine, gave us the first indication of changing attitudes amongst volunteers whilst in quarantine. These quarantine experiments, referred to as challenge studies, human infection studies, or "controlled human infection models" involve thousands of clinical samples taken over two to three weeks and can provide a wealth of immunological and molecular data on the infection itself and could allow the discovery of new targets for vaccines and therapeutics. The Yellow Fever studies from 121 years ago gave the impetus for development of a successful vaccine still used today whilst also uncovering the nature of the Yellow Fever agent, namely that it was a virus. We outline how carefully these experiments are approached and the necessity to have high quality units with self-contained air-flow along with extensive personal protective equipment for nursing and medical staff. Most important is the employment of highly trained scientific, medical and nursing staff. We face a future of emerging pathogens driven by the increasing global population, deforestation, climate change, antibiotic resistance and increased global travel. These emerging pathogens may be pathogens we currently are not aware of or have not caused outbreaks historically but could also be mutated forms of known pathogens including viruses such as influenza (H7N9, H5N1 etc.) and coronaviruses. This calls for challenge studies to be part of future pandemic preparedness as an additional tool to assist with the rapid development of broad-spectrum antimicrobials, immunomodulators and new vaccines.

摘要

400 年前的威尼斯隔离是一项重要的公共卫生措施。自 1900 年以来,这一措施已经得到了完善,包括“挑战”或故意感染病原体,无论是病毒、细菌还是寄生虫。我们的研究重点是病毒学,范围从古巴早期的黄热病病毒实验到我们当前最广泛的病原体 COVID-19。后者迄今为止已在全球造成超过 400 万人死亡和 1.9 亿例疾病。隔离和挑战也被用于研究 1918 年的西班牙流感,该流感导致超过 1 亿人死亡。在这里,我们考虑了这种方法的优点,即在实践中加速知识的获取,从而更快速地获得疫苗和抗生素的许可。隔离和挑战计划的核心是设计单位,以确保病原体的安全隔离和工作人员的保护。然而,最重要的是志愿者的安全。我们现在可以看到,就像 1900 年一样,我们社会的成员已经做好了准备,并愿意为了公众利益参与这些实验。我们的民族学研究,调查员从隔离区内观察实验,首先表明志愿者在隔离期间的态度发生了变化。这些被称为挑战研究、人体感染研究或“受控人体感染模型”的隔离实验涉及在两到三周内采集数千份临床样本,可以提供大量关于感染本身的免疫学和分子数据,并可以发现疫苗和疗法的新靶点。121 年前的黄热病研究为今天仍在使用的成功疫苗的开发提供了动力,同时也揭示了黄热病病原体的性质,即它是一种病毒。我们概述了如何谨慎地进行这些实验,以及有必要建立高质量的单位,这些单位具有独立的气流,并为护理和医务人员配备广泛的个人防护设备。最重要的是,要雇用训练有素的科学、医疗和护理人员。我们面临着由全球人口增长、森林砍伐、气候变化、抗生素耐药性和全球旅行增加驱动的新出现的病原体的未来。这些新出现的病原体可能是我们目前尚未意识到的病原体,或者历史上从未引起过疫情,但也可能是已知病原体(如流感病毒[H7N9、H5N1 等]和冠状病毒)的突变形式。这就要求挑战研究成为未来大流行准备的一部分,作为一种额外的工具,以协助快速开发广谱抗生素、免疫调节剂和新疫苗。

相似文献

1
A Brief History of Human Challenge Studies (1900-2021) Emphasising the Virology, Regulatory and Ethical Requirements, Raison D'etre, Ethnography, Selection of Volunteers and Unit Design.人类挑战研究简史(1900-2021),重点介绍病毒学、监管和伦理要求、存在理由、民族志、志愿者选择和单位设计。
Curr Top Microbiol Immunol. 2024;445:1-32. doi: 10.1007/82_2022_253.
2
Pandemics: COVID-19.大流行:2019冠状病毒病
Cir Cir. 2020;88(3):249-251. doi: 10.24875/CIRU.20000234.
3
The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.新冠病毒严重感染高风险的5%人群是可识别的,在经济重启时需要予以考虑。
J Psychiatr Pract. 2020 May;26(3):219-227. doi: 10.1097/PRA.0000000000000475.
4
How Italy's 'father of the swabs' fought the virus.意大利“拭子之父”如何抗击病毒。
Science. 2020 Aug 28;369(6507):1040-1041. doi: 10.1126/science.369.6507.1040.
5
Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.单独隔离或与其他公共卫生措施相结合以控制新冠病毒病:一项快速综述
Cochrane Database Syst Rev. 2020 Apr 8;4(4):CD013574. doi: 10.1002/14651858.CD013574.
6
Reporting COVID-19: A Conversation with Jon Cohen of Science.报道新冠疫情:与《科学》杂志的乔恩·科恩对话
Am J Trop Med Hyg. 2020 Oct;103(4):1744-1747. doi: 10.4269/ajtmh.20-1034.
7
Fast Mass-Production of Medical Safety Shields under COVID-19 Quarantine: Optimizing the Use of University Fabrication Facilities and Volunteer Labor.新冠疫情下的医疗安全护罩快速量产:优化利用大学制造设施和志愿者劳动力。
Int J Environ Res Public Health. 2020 May 14;17(10):3418. doi: 10.3390/ijerph17103418.
8
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.一种表达融合前稳定的 SARS-CoV-2 刺突蛋白的麻疹载体候选疫苗已进入 I/II 期临床试验:保护非洲绿猴免受 COVID-19 疾病。
J Virol. 2024 May 14;98(5):e0176223. doi: 10.1128/jvi.01762-23. Epub 2024 Apr 2.
9
Emerging and reemerging respiratory viral infections up to Covid-19.新兴和重现的呼吸道病毒感染,直至新冠病毒。
Turk J Med Sci. 2020 Apr 21;50(SI-1):557-562. doi: 10.3906/sag-2004-126.
10
China's successful control of COVID-19.中国对新冠疫情的成功防控。
Lancet Infect Dis. 2020 Nov;20(11):1240-1241. doi: 10.1016/S1473-3099(20)30800-8. Epub 2020 Oct 8.

引用本文的文献

1
Best Practices in the Development and Use of Experimental Models of Bacterial Pneumonia: An Official American Thoracic Society Workshop Report.细菌性肺炎实验模型开发与应用的最佳实践:美国胸科学会官方研讨会报告
Am J Respir Cell Mol Biol. 2025 Aug;73(2):178-199. doi: 10.1165/rcmb.2025-0322ST.

本文引用的文献

1
"At first, I was very afraid"-a qualitative description of participants' views and experiences in the first Human Infection Study in Malawi.“起初,我非常害怕”——对马拉维首次人类感染研究中参与者观点和经历的定性描述。
Wellcome Open Res. 2021 Oct 4;6:89. doi: 10.12688/wellcomeopenres.16587.2. eCollection 2021.
2
Impact of PCV13 vaccination in Blantyre, Malawi.13价肺炎球菌结合疫苗(PCV13)接种在马拉维布兰太尔的影响。
Lancet Glob Health. 2021 Jul;9(7):e893-e894. doi: 10.1016/S2214-109X(21)00258-8.
3
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection.
人体挑战研究与志贺氏菌生物缀合疫苗:临床疗效和保护相关因素分析。
EBioMedicine. 2021 Apr;66:103310. doi: 10.1016/j.ebiom.2021.103310. Epub 2021 Apr 13.
4
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.COVID-19 人体挑战研究的伦理可接受性的关键标准:世卫组织工作组的报告。
Vaccine. 2021 Jan 22;39(4):633-640. doi: 10.1016/j.vaccine.2020.10.075. Epub 2020 Oct 28.
5
Multi-Omic Data Integration Allows Baseline Immune Signatures to Predict Hepatitis B Vaccine Response in a Small Cohort.多组学数据整合可使基线免疫特征预测小队列乙型肝炎疫苗应答。
Front Immunol. 2020 Nov 30;11:578801. doi: 10.3389/fimmu.2020.578801. eCollection 2020.
6
Public perceptions on Controlled Human Infection Model (CHIM) studies-a qualitative pilot study from South India.公众对人体受控感染模型(CHIM)研究的看法——来自印度南部的一项定性试点研究。
Monash Bioeth Rev. 2021 Jul;39(1):68-93. doi: 10.1007/s40592-020-00121-1. Epub 2020 Oct 21.
7
Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials.在英国的“人体挑战”试验中,数十人将被故意感染新冠病毒。
Nature. 2020 Oct;586(7831):651-652. doi: 10.1038/d41586-020-02821-4.
8
Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers.世界卫生组织咨询小组观点:考虑在健康志愿者中建立密切监测的 2019 年冠状病毒病(COVID-19)挑战模型。
Clin Infect Dis. 2021 Jun 1;72(11):2035-2041. doi: 10.1093/cid/ciaa1290.
9
Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study.口服流感疫苗的疗效、免疫原性和安全性:一项安慰剂对照和活性对照的 2 期人体挑战研究。
Lancet Infect Dis. 2020 Apr;20(4):435-444. doi: 10.1016/S1473-3099(19)30584-5. Epub 2020 Jan 21.
10
Expert voices and equal partnerships: establishing Controlled Human Infection Models (CHIMs) in Vietnam.专家意见与平等伙伴关系:在越南建立人类感染控制模型(CHIMs)。
Wellcome Open Res. 2019 Sep 25;4:143. doi: 10.12688/wellcomeopenres.15337.1. eCollection 2019.